Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62,500,000
-
Total 13F shares
-
25,998,128
-
Share change
-
+6,147,495
-
Total reported value
-
$729,236,893
-
Put/Call ratio
-
98%
-
Price per share
-
$28.05
-
Number of holders
-
100
-
Value change
-
+$172,243,077
-
Number of buys
-
66
-
Number of sells
-
31
Institutional Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q4 2016
As of 31 Dec 2016,
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,998,128 shares.
The largest 10 holders included
FMR LLC, BVF INC/IL, DEERFIELD MANAGEMENT CO, WELLINGTON MANAGEMENT GROUP LLP, LORD, ABBETT & CO. LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, Opaleye Management Inc., and Cormorant Asset Management, LLC.
This page lists
100
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.